Steroid dementia syndrome describes the signs and symptoms of hippocampal and prefrontal cortical dysfunction, such as deficits in memory (both short term and long term), attention, and executive function, induced by corticoids. Dementia-like symptoms have been found in some individuals who have been exposed to glucocorticoid medication, often dispensed in the form of asthma, arthritis, and anti-inflammatory steroid. The term "steroid dementia" was coined by Varney et al. (1984) in reference to the effects of long-term glucocorticoid use in 1,500 patients. While the condition generally falls under the classification of Cushing's syndrome, the term "steroid dementia syndrome" is particularly useful because it recognizes both the cause of the syndrome and the specific effects of glucocorticoids on cognitive function. Further, the more precise terminology clearly distinguishes the condition from full-blown Cushing's syndrome, which is extremely broad regarding the causes (endogenous or exogenous, pituitary or adrenal) and the multitude of symptoms (ranging from skin disorders to osteoporosis), and from hypercortisolemia, which identifies neither the source nor the symptoms of excess circulatory cortisol.
Signs and symptoms Cognitive symptoms from steroids appear within the first few weeks of treatment, appear to be dose dependent, and may or may not be accompanied by steroid psychosis or other Cushing's-type symptoms. The symptoms include deficits in
verbal and non-verbal memory working memory attention sustained concentration executive function psychomotor speed academic or occupational performance. These symptoms have been shown to improve within months to a year after discontinuing glucocorticoid medication, but residual impairments following prolonged steroid use can remain.
Pathophysiology Regions of the brain with a high density of glucocorticoid receptors (GRs) including the hippocampus, hypothalamus, and prefrontal cortex are particularly sensitive to elevated circulating levels of glucocorticoids even in the absence of stress. Scientific studies have mainly focused on the impact of glucocorticoids on the hippocampus because of its role in memory processes and on the prefrontal cortex for its role in attention and executive function. Elevated glucocorticoid activity is associated with down-regulation of GRs (known as "glucocorticoid cascade hypothesis"), which diminishes neuroreparative activity and attenuates neurogenesis that can result in decreased hippocampal volume with prolonged glucocorticoid exposure. Variations in individual sensitivity to glucocorticoid medications may be due to either GR hypofunction or hyperfunction. Similarly, variations in individual hypothalamic-pituitary-adrenal (HPA) axis responsiveness can modulate the type and number of side effects. Steroid Dementia Syndrome is caused by prolonged exposure to glucocorticoid levels which directly affect structures and functions of the brain which are involved in cognition and emotion regulation. Research has shown that exposure from chronic glucocorticoid affects the areas of the hippocampus, prefrontal cortex, and amygdala. These three areas that are shown to be affected contain high concentrations of the receptors for glucocorticoid. The most vulnerable hippocampus, this exposure becomes vulnerable as it plays a role in memory and learning. Studies have also shown that with excess cortisol exposure, hippocampal glucose metabolism is slowed while also decreasing hippocampal activity. This is linked with impairments with learning and retention in memory. With long term glucocorticoid exposure, there have been associations with volume in the hippocampus, along with neuronal atrophy. These elevated levels of cortisol suppress brain derived neurotrophic factors while also contributing to neuronal damage through increased glutamate activity. In the prefrontal cortex, the effects that this causes are impairment in executive function and attention. Meanwhile changes in the amygdala are associated with anxiety, emotional dysregulation, and disturbances in mood. These alterations in neurobiology explain how cognitive changes and psychiatric symptoms come with Steroid Dementia Syndrome.
Treatment Aside from discontinuation of glucocorticoid medication, potential treatments discussed in the research literature include:
anti-glucocorticoids psychoactive drugs that up-regulate the GRII glucocorticoid receptor: tricyclic antidepressants: desipramine, imipramine, and amitriptyline (SSRIs do not) serotonin antagonists: ketanserin mood stabilizers: lithium corticotropin-releasing hormone (CRH) antagonists glutamate antagonists dehydroepiandrosterone (DHEA) small molecule brain-derived neurotrophic factor (BDNF) analogs stress reduction therapies and exercise.
History Glucocorticoid medications have been known to be associated with significant side effects involving behavior and mood, regardless of previous psychiatric or cognitive condition, since the early 1950s. But cognitive side effects of steroid medications involving memory and attention are not as widely publicized and may be misdiagnosed as separate conditions, such as attention deficit disorder (ADHD or ADD) in children or early Alzheimer's disease in elderly patients.
… excerpt ends here. Continue reading the full article.
